Gilead Stock Performance

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>GS</div>
GILD -- USA Stock  

Report: 4th of August 2020  

The company retains a Market Volatility (i.e. Beta) of 0.1876, which attests to not very significant fluctuations relative to the market. Let's try to break down what Gilead's beta means in this case. As returns on the market increase, Gilead Sciences returns are expected to increase less than the market. However, during the bear market, the loss on holding Gilead Sciences will be expected to be smaller as well. Although it is extremely important to respect Gilead Sciences current price history, it is better to be realistic regarding the information on equity current price movements. The philosophy towards determining future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By evaluating Gilead Sciences technical indicators, you can presently evaluate if the expected return of 0.0047% will be sustainable into the future. Gilead Sciences right now retains a risk of 2.63%. Please check out Gilead Sciences jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall to decide if Gilead Sciences will be following its current trending patterns.

Search Stock Performance

 
Refresh
00

Gilead Sciences Risk-Adjusted Performance

Over the last 30 days Gilead Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental drivers, Gilead Sciences is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Quick Ratio2.82
Fifty Two Week Low60.89
Target High Price97.00
Payout Ratio65.90%
Fifty Two Week High85.97
Target Low Price58.00
Trailing Annual Dividend Yield3.36%

Gilead Sciences Relative Risk vs. Return Landscape

If you would invest  7,775  in Gilead Sciences on June 13, 2020 and sell it today you would lose (143.00)  from holding Gilead Sciences or give up 1.84% of portfolio value over 30 days. Gilead Sciences is currently generating 0.0047% in daily expected returns and assumes 2.6314% risk (volatility on return distribution) over the 30 days horizon. In different words, 22% of equities are less volatile than Gilead Sciences and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
 Daily Expected Return (%) 
      Risk (%) 
Given the investment horizon of 30 days, Gilead Sciences is expected to generate 36.09 times less return on investment than the market. In addition to that, the company is 1.47 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.1 per unit of volatility.

Gilead Sciences Market Risk Analysis

Sharpe Ratio = 0.0018
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsGILD

Gilead Sciences Stock Performance Indicators

Estimated Market Risk
 2.63
  actual daily
 
 22 %
of total potential
 
2222
Expected Return
 0.0
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 0.0
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Gilead Sciences is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Gilead Sciences by adding it to a well-diversified portfolio.

About Gilead Sciences Performance

To evaluate Gilead Sciences Stock as a possible investment, you need to clearly understand its upside, downside potential, and overall future performance outlook. You may be satisfied when Gilead Sciences generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Gilead's stock performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Gilead Sciences stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Gilead's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2020
Effect of Exchange Rate Changes on Cash-2 M-2.1 M
Return on Investment 8.95  9.18 
Return on Average Assets 0.09  0.14 
Return on Average Equity 0.25  0.33 
Return on Invested Capital 0.13  0.14 
Return on Sales 0.28  0.35 
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. Gilead Sciences, Inc. was founded in 1987 and is headquartered in Foster City, California. Gilead Sciences operates under Drug ManufacturersGeneral classification in the United States and is traded on BATS Exchange. It employs 11800 people.

Gilead Sciences Alerts

Equity Alerts and Improvement Suggestions

Over 81.0% of the company shares are owned by institutional investors
On 11th of June 2020 Gilead Sciences paid $ 0.68 per share dividend to its current shareholders

Gilead Sciences Dividends

Gilead Sciences Dividends Analysis

Check Gilead Sciences dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Please check Risk vs Return Analysis. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page